MarketPeel
Insider Trading Intelligence
Pricing
…
MI

Mark T. Iwicki

KALA
CHIEF EXECUTIVE OFFICER · KALA BIO, INC. · CIK 0001415537
FILING MIX · LIFETIME55%/45%
BUYS
32
SELLS
26
TOTAL VALUE
$569.6K
COMPANIES
4
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
5,111,056
AVG SELL PX
$1.99
TRADE KIND
SHOWING 58 / 58
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
14 backtested trades · 8 horizons · 6 pending
Forward-return performance of every backtestable P/S trade by Mark T. Iwicki, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d14+64.29%-0.85%+0.55%-1.40%-4.01%—
14d14+50.00%+0.92%+0.77%+0.15%+1.33%—
30d14+57.14%+2.32%+2.74%-0.42%-3.79%—
60d14+71.43%+5.94%+2.78%+3.15%-15.36%—
90d14+57.14%+48.01%+2.67%+45.34%-9.46%—
180d14+71.43%+200.87%+7.44%+193.43%-67.53%—
1y14(1 pending)+53.85%+618.22%+8.78%+739.83%-15.38%—
2y14(5 pending)+77.78%-19.78%+30.24%-44.14%-87.51%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
KALA · 103,540 shares · as of Oct 23, 2025
0193,750387,500581,250775,00020212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 32 buys / 26 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
QTTB
Q32 BIO INC.
PURCHASEGRANT
Stock grant
9,810——9,810Jun 12, 2026Jun 16, 2026 ↗View →
IKT
INHIBIKASE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,982,706——4,982,706Jan 5, 2026Jan 7, 2026 ↗View →
KALA
KALA BIO, INC.
SALE
154,894$0.81$125.5K103,540Oct 23, 2025Oct 24, 2025 ↗View →
QTTB
Q32 BIO INC.
PURCHASEGRANT
Stock grant
53,521——53,521Oct 23, 2025Oct 27, 2025 ↗View →
KALA
KALA BIO, INC.
SALE
13,227$4.01$53.0K258,433Jun 24, 2025Jun 26, 2025 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
2,450——271,660Jun 15, 2025Jun 17, 2025 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
5,450——5,450Jun 15, 2025Jun 17, 2025 ↗View →
KALA
KALA BIO, INC.
PURCHASE
10,866$3.74$40.6K269,210Jun 3, 2025Jun 4, 2025 ↗View →
KALA
KALA BIO, INC.
SALE
10,866$3.74$40.6K269,210Jun 3, 2025Jun 5, 2025 ↗View →
QTTB
Q32 BIO INC.
SALE
7,615——0Feb 24, 2025Feb 26, 2025 ↗View →
QTTB
Q32 BIO INC.
SALE
37,222——0Feb 24, 2025Feb 26, 2025 ↗View →
QTTB
Q32 BIO INC.
PURCHASEGRANT
Stock grant
37,222——37,222Feb 24, 2025Feb 26, 2025 ↗View →
QTTB
Q32 BIO INC.
PURCHASEGRANT
Stock grant
25,534——25,534Feb 24, 2025Feb 26, 2025 ↗View →
QTTB
Q32 BIO INC.
SALE
25,534——0Feb 24, 2025Feb 26, 2025 ↗View →
QTTB
Q32 BIO INC.
PURCHASEGRANT
Stock grant
7,615——7,615Feb 24, 2025Feb 26, 2025 ↗View →
IKT
INHIBIKASE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
602,346——602,346Feb 21, 2025Jul 2, 2025 ↗View →
IKT
INHIBIKASE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
602,346——602,346Feb 21, 2025Feb 25, 2025 ↗View →
IKT
INHIBIKASE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,794,291——1,794,291Feb 17, 2025Feb 19, 2025 ↗View →
IKT
INHIBIKASE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,373,857——4,373,857Feb 14, 2025Feb 19, 2025 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
99,500——99,500Jan 6, 2025Jan 7, 2025 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
22,100——285,855Jan 6, 2025Jan 7, 2025 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
5,779$7.63$44.1K280,076Jan 6, 2025Jan 7, 2025 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
15,168$4.75$72.0K263,755Jun 26, 2024Jun 27, 2024 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
7,392$6.09$45.0K278,923May 31, 2024Jun 3, 2024 ↗View →
QTTB
Q32 BIO INC.
PURCHASEGRANT
Stock grant
25,534——25,534Mar 25, 2024Mar 27, 2024 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
4,539$6.73$30.5K286,315Jan 4, 2024Jan 5, 2024 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
14,300——290,854Jan 4, 2024Jan 5, 2024 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
64,500——64,500Jan 4, 2024Jan 5, 2024 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
158,873——276,554Jun 22, 2023Jun 23, 2023 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
211,831——211,831Jun 22, 2023Jun 23, 2023 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
1,572——0May 31, 2023Jun 2, 2023 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
7,299——0May 31, 2023Jun 2, 2023 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
2,268——0May 31, 2023Jun 2, 2023 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
5,449——0May 31, 2023Jun 2, 2023 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
9,199——0May 31, 2023Jun 2, 2023 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
6,059——0May 31, 2023Jun 2, 2023 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
7,576——0May 31, 2023Jun 2, 2023 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
15,499——0May 31, 2023Jun 2, 2023 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
12,195——0May 31, 2023Jun 2, 2023 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
4,599——0May 31, 2023Jun 2, 2023 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
71,715——117,681May 31, 2023Jun 2, 2023 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
1,512——1,512Mar 14, 2023Mar 15, 2023 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
41,700——46,164Jan 4, 2023Jan 6, 2023 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
198$28.54$5.7K45,966Jan 4, 2023Jan 6, 2023 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
561$6.52$3.7K4,464Oct 26, 2022Oct 28, 2022 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
7,975$0.37$3.0K251,183Jun 27, 2022Jun 29, 2022 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
9,518$1.30$12.4K259,158Jan 4, 2022Jan 5, 2022 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
775,000——775,000Jan 3, 2022Jan 5, 2022 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
27,598$1.80$49.7K268,676Oct 26, 2021Oct 28, 2021 ↗View →
KALA
KALA BIO, INC.
SALE
CHIEF EXECUTIVE OFFICER
7,586$5.77$43.8K296,274Jun 28, 2021Jun 29, 2021 ↗View →
PULM
PULMATRIX, INC.
PURCHASEGRANT
Stock grant
15,000——15,000Jan 28, 2021Feb 1, 2021 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
303,000——303,000Jan 4, 2021Jan 5, 2021 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
76,000——303,860Jan 4, 2021Jan 5, 2021 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
178,300——227,860Oct 26, 2020Oct 28, 2020 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
49,560——49,560Jun 25, 2020Jun 29, 2020 ↗View →
PULM
PULMATRIX, INC.
PURCHASEGRANT
Stock grant
10,000——10,000Apr 2, 2020Apr 6, 2020 ↗View →
PULM
PULMATRIX, INC.
PURCHASEGRANT
Stock grant
15,000——15,000Jan 9, 2020Jan 13, 2020 ↗View →
KALA
KALA BIO, INC.
PURCHASEGRANT
Stock grant
365,000——365,000Jan 2, 2020Jan 3, 2020 ↗View →
Other insiders · KALA
Loading peer insiders…
About this filer
CIK 0001415537
ROLE
CHIEF EXECUTIVE OFFICER
PRIMARY
KALA
COMPANIES
4
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001415537DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback